Callisto Pharmaceuticals to Present at the Acumen Biofin Rodman & Renshaw 4th Annual Global Healthcare Conferences
Callisto Pharmaceuticals, Inc. (“KAL”, Amex) announced today that Gary Jacob, Ph.D., Callisto’s CEO and CSO, is scheduled to present on Monday, May 14, 2007 at 10:05 a.m. Central European Time in the Atlantique Salon – Western during the Acumen Biofin Rodman & Renshaw 4th Annual Global Healthcare Conference. The conference is being held at Le…